167 related articles for article (PubMed ID: 37288716)
21. Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria.
Jindal A; Sharma S; Agarwal S; Kumar M; Saraya A; Sarin SK
Hepatol Int; 2022 Feb; 16(1):89-98. PubMed ID: 35072932
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
Jindal A; Agarwal S; Sharma S; Kumar M; Saraya A; Sarin SK
Dig Dis Sci; 2023 May; 68(5):2149-2157. PubMed ID: 36562888
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
Pons M; Augustin S; Scheiner B; Guillaume M; Rosselli M; Rodrigues SG; Stefanescu H; Ma MM; Mandorfer M; Mergeay-Fabre M; Procopet B; Schwabl P; Ferlitsch A; Semmler G; Berzigotti A; Tsochatzis E; Bureau C; Reiberger T; Bosch J; Abraldes JG; Genescà J
Am J Gastroenterol; 2021 Apr; 116(4):723-732. PubMed ID: 33982942
[TBL] [Abstract][Full Text] [Related]
24. Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography.
Grgurevic I; Madir A; Trkulja V; Bozin T; Aralica G; Podrug K; Mikolaševic I; Tsochatzis E; O'Beirne J; Pinzani M
Eur J Clin Invest; 2022 Jun; 52(6):e13750. PubMed ID: 35040495
[TBL] [Abstract][Full Text] [Related]
25. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease.
Thorhauge KH; Semmler G; Johansen S; Lindvig KP; Kjærgaard M; Hansen JK; Torp N; Hansen CD; Andersen P; Hofer BS; Gu W; Israelsen M; Mandorfer M; Reiberger T; Trebicka J; Thiele M; Krag A;
J Hepatol; 2024 Jul; 81(1):23-32. PubMed ID: 38428644
[TBL] [Abstract][Full Text] [Related]
26. Utility of different Baveno criteria to detect esophageal varices irrespective of their size in patients with compensated cirrhosis.
Ahmed S; Sharma S; Agarwal S; Wong YJ; Putera M; Saraya A
Indian J Gastroenterol; 2023 Oct; ():. PubMed ID: 37840111
[TBL] [Abstract][Full Text] [Related]
27. Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.
Reiniš J; Petrenko O; Simbrunner B; Hofer BS; Schepis F; Scoppettuolo M; Saltini D; Indulti F; Guasconi T; Albillos A; Téllez L; Villanueva C; Brujats A; Garcia-Pagan JC; Perez-Campuzano V; Hernández-Gea V; Rautou PE; Moga L; Vanwolleghem T; Kwanten WJ; Francque S; Trebicka J; Gu W; Ferstl PG; Gluud LL; Bendtsen F; Møller S; Kubicek S; Mandorfer M; Reiberger T
J Hepatol; 2023 Feb; 78(2):390-400. PubMed ID: 36152767
[TBL] [Abstract][Full Text] [Related]
28. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis.
Villanueva C; Torres F; Sarin SK; Shah HA; Tripathi D; Brujats A; Rodrigues SG; Bhardwaj A; Azam Z; Hayes PC; Jindal A; Abid S; Alvarado E; Bosch J;
J Hepatol; 2022 Oct; 77(4):1014-1025. PubMed ID: 35661713
[TBL] [Abstract][Full Text] [Related]
29. Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.
Burghart L; Halilbasic E; Schwabl P; Simbrunner B; Stättermayer AF; Petrenko O; Scheiner B; Bauer D; Pinter M; Boztug K; Mandorfer M; Trauner M; Reiberger T
J Gastroenterol; 2022 Feb; 57(2):99-110. PubMed ID: 34893924
[TBL] [Abstract][Full Text] [Related]
30. Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension.
Semmler G; Hartl L; Mendoza YP; Simbrunner B; Jachs M; Balcar L; Schwarz M; Hofer BS; Fritz L; Schedlbauer A; Stopfer K; Neumayer D; Maurer J; Szymanski R; Meyer EL; Scheiner B; Quehenberger P; Trauner M; Aigner E; Berzigotti A; Reiberger T; Mandorfer M
Hepatology; 2024 Mar; ():. PubMed ID: 38447034
[TBL] [Abstract][Full Text] [Related]
31. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.
Paternostro R; Kwanten WJ; Hofer BS; Semmler G; Bagdadi A; Luzko I; Hernández-Gea V; Graupera I; García-Pagán JC; Saltini D; Indulti F; Schepis F; Moga L; Rautou PE; Llop E; Téllez L; Albillos A; Fortea JI; Puente A; Tosetti G; Primignani M; Zipprich A; Vuille-Lessard E; Berzigotti A; Taru MG; Taru V; Procopet B; Jansen C; Praktiknjo M; Gu W; Trebicka J; Ibanez-Samaniego L; Bañares R; Rivera-Esteban J; Pericas JM; Genesca J; Alvarado E; Villanueva C; Larrue H; Bureau C; Laleman W; Ardevol A; Masnou H; Vanwolleghem T; Trauner M; Mandorfer M; Francque S; Reiberger T;
J Hepatol; 2024 May; ():. PubMed ID: 38823501
[TBL] [Abstract][Full Text] [Related]
32. Enhancing liver cirrhosis varices and CSPH risk prediction with spleen stiffness measurement using 100-Hz probe.
Yoo JJ; Maeng SA; Chang Y; Lee SH; Jeong SW; Jang JY; Cheon GJ; Kim YS; Kim HS; Kim SG
Sci Rep; 2024 Jun; 14(1):13674. PubMed ID: 38871788
[TBL] [Abstract][Full Text] [Related]
33. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
[TBL] [Abstract][Full Text] [Related]
34. CHESS-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: An international multicenter study.
Wong YJ; Li J; Liu C; Chen Z; Chan YH; Putera M; Teh KB; Ang TL; Zhao L; Yan Z; Kumar R; Li X; Qi X
J Gastroenterol Hepatol; 2022 Jun; 37(6):1043-1051. PubMed ID: 35253271
[TBL] [Abstract][Full Text] [Related]
35. Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis.
Dallio M; Romeo M; Vaia P; Auletta S; Mammone S; Cipullo M; Sapio L; Ragone A; Niosi M; Naviglio S; Federico A
World J Gastroenterol; 2024 Feb; 30(7):685-704. PubMed ID: 38515952
[TBL] [Abstract][Full Text] [Related]
36. Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey.
Rodrigues SG
Clin Mol Hepatol; 2023 Jan; 29(1):110-112. PubMed ID: 36503206
[No Abstract] [Full Text] [Related]
37. Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications.
Kitson MT; Roberts SK; Colman JC; Paul E; Button P; Kemp W
Scand J Gastroenterol; 2015 Apr; 50(4):462-9. PubMed ID: 25623641
[TBL] [Abstract][Full Text] [Related]
38. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
Semmler G; Alonso López S; Pons M; Lens S; Dajti E; Griemsmann M; Zanetto A; Burghart L; Hametner-Schreil S; Hartl L; Manzano M; Rodriguez-Tajes S; Zanaga P; Schwarz M; Gutierrez ML; Jachs M; Pocurull A; Polo B; Ecker D; Mateos B; Izquierdo S; Real Y; Ahumada A; Bauer DJM; Mauz JB; Casanova-Cabral M; Gschwantler M; Russo FP; Azzaroli F; Maasoumy B; Reiberger T; Forns X; Genesca J; Bañares R; Mandorfer M;
J Hepatol; 2024 Jul; 81(1):76-83. PubMed ID: 38521170
[TBL] [Abstract][Full Text] [Related]
39. [Role and clinical meaning of non-invasive tests in the evaluation of portal hypertension in patients with advanced chronic liver disease].
Festi D; Dajti E; Ravaioli F; Marasco G; Colecchia A
Recenti Prog Med; 2018 Dec; 109(12):574-584. PubMed ID: 30667387
[TBL] [Abstract][Full Text] [Related]
40. [Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient].
Jiang FR; Yan HD
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):995-1000. PubMed ID: 34814395
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
